1-1 of 1
Karin Berg
Close
Sort by
Journal Articles

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

Clinical Trials & Observations
B. Douglas Smith, Mark Levis, Miloslav Beran, Francis Giles, Hagop Kantarjian, Karin Berg, Kathleen M. Murphy, Tianna Dauses, Jeffrey Allebach, Donald Small
Journal: Blood
Blood (2004) 103 (10): 3669–3676.
https://doi.org/10.1182/blood-2003-11-3775
Published: 2004